NIH #R01CA255442
Strategy for combining circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) measures of tumor burden for prediction of response and outcome in neoadjuvant-treated early breast cancer
Expiring Soon
- Amount
- $600K–$700K
- Period
- 2020-12-03 → 2026-11-30
- PIs
- 3